The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Research Shows High Adherence to Performance Measures for RA Cohort

Research Shows High Adherence to Performance Measures for RA Cohort

June 7, 2018 • By Arthritis Care & Research

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Due to appointment scheduling and insurer requirements, a 14-month window seems optimal for measuring follow-up, the researchers write. However, they also note that more research is needed to determine if adherence to a 12- vs. a 14-month window of follow-up affects patient outcomes.

You Might Also Like
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
  • Personal Beliefs Affect Medication Adherence for RA Patients
  • EULAR 2015: RA Research Shows Imperfect Guidelines, Suggests Strategies with Biologics

In the study, the percentage of DMARD-treated early RA patients was and remained high (95–87%). Additionally, the percentage of patients receiving DMARDs within 14 days of diagnosis was 75%. Median time-to-DMARD therapy was one day, indicating DMARDs were initiated at diagnosis. Prior research links delays in starting DMARD therapy to worse outcomes for patients. “Most significant delays to therapy occur due to delays in access to rheumatology [care] and time-to-DMARD start [after] a patient is seen by a rheumatologist is often negligible, a finding confirmed by our study,” note the authors.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The authors conclude by noting that testing performance measures is crucial prior to implementation. “Additionally, future studies examining patient and provider factors that impact measure performance will be important to conduct, to better understand how to improve any observed gaps in care. [Although] the rates of adherence in this cohort were high, lower adherence will perhaps be observed with other data sources, but the current results may be used in benchmarking.”

Read the full article.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Barber CEH, Schieir O, Lacaille D, et al. High adherence to system-level performance measures for rheumatoid arthritis in a national early arthritis cohort over eight years. Arthritis Care Res (Hoboken). 2018 Jun;70(6):842–850.

Pages: 1 2 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: adherence, Arthritis Care & Research, Canada, Canadian Early Arthritis Cohort, early arthritis, Rheumatoid Arthritis (RA)

You Might Also Like:
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
  • Personal Beliefs Affect Medication Adherence for RA Patients
  • EULAR 2015: RA Research Shows Imperfect Guidelines, Suggests Strategies with Biologics
  • Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.